Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
The Long Run with Luke Timmerman
Introduction
Exploring VOR Bio's mission to delete CD33 antigen from stem cells using CRISPR gene editing for the treatment of acute myeloid leukemia, along with their development of a CD33-directed CAR-T cell therapy. Guest Robert Ang shares his journey as an immigrant physician turned entrepreneur in biotech.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
